These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16631737)

  • 1. Immune modulation by mesenchymal stem cells.
    Rasmusson I
    Exp Cell Res; 2006 Jul; 312(12):2169-79. PubMed ID: 16631737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
    Zhao ZG; Li WM; Chen ZC; You Y; Zou P
    Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune regulation by mesenchymal stem cells: two sides to the coin.
    Stagg J
    Tissue Antigens; 2007 Jan; 69(1):1-9. PubMed ID: 17212702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
    Groh ME; Maitra B; Szekely E; Koç ON
    Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
    Maccario R; Moretta A; Cometa A; Montagna D; Comoli P; Locatelli F; Podestà M; Frassoni F
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1031-2. PubMed ID: 16338626
    [No Abstract]   [Full Text] [Related]  

  • 17. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells.
    Prigione I; Benvenuto F; Bocca P; Battistini L; Uccelli A; Pistoia V
    Stem Cells; 2009 Mar; 27(3):693-702. PubMed ID: 19096038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.
    Li C; Zhang W; Jiang X; Mao N
    Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.